OTCMKTS:NVZMF

Novozymes A/S (NVZMF) Stock Price, News & Analysis

$55.22
+2.71 (+5.16%)
(As of 04/25/2024 ET)
Today's Range
$55.22
$55.22
50-Day Range
$52.51
$61.17
52-Week Range
$38.85
$62.80
Volume
100 shs
Average Volume
2,206 shs
Market Capitalization
N/A
P/E Ratio
6.89
Dividend Yield
3.26%
Price Target
N/A

Novozymes A/S MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.69mentions of Novozymes A/S in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.41 out of 5 stars

NVZMF stock logo

About Novozymes A/S Stock (OTCMKTS:NVZMF)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

NVZMF Stock Price History

NVZMF Stock News Headlines

“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
Trading by management and close relations of management
Recap: Novozymes Q4 Earnings
Results update for 2023 – unaudited
Legacy Novozymes delivers solid last full-year results
“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
Novozymes A/S B (0Q4U)
Novozymes A/S Class B NVZMF
Not Just Yogurt Anymore
ESI or NVZMY: Which Is the Better Value Stock Right Now?
Novozymes A/S B (NZYMb)
Novozymes delivers stronger than expected Q1 results
See More Headlines
Receive NVZMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/20/2016
Today
4/25/2024

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:NVZMF
Fax
N/A
Employees
6,397
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Ms. Ester Baiget (Age 53)
    President & CEO
    Comp: $2.8M
  • Mr. Rainer Lehmann (Age 49)
    Executive VP & CFO
    Comp: $755.41k
  • Mr. Anders Lund (Age 51)
    Chief Operating Officer
    Comp: $915.21k
  • Mr. Claus Crone Fuglsang (Age 56)
    Chief Scientific Officer
  • Mr. Tobias Cornelius Bjorklund
    Head of Investor Relations
  • Ms. Winnie Hoejvang Bugel (Age 59)
    General Counsel of Legal
  • Mr. Tue Micheelsen
    Vice President of Global Sales & Marketing
  • Mr. Morten Enggaard Rasmussen (Age 48)
    Executive Vice President of People & Stakeholder Relations
  • Ms. Tina Sejersgaard Fano (Age 55)
    Executive Vice President of Planetary Health Biosolutions
    Comp: $900.68k
  • Ms. Amy Byrick (Age 50)
    Executive Vice President of Human Health Biosolutions

NVZMF Stock Analysis - Frequently Asked Questions

How have NVZMF shares performed in 2024?

Novozymes A/S's stock was trading at $54.99 at the beginning of the year. Since then, NVZMF shares have increased by 0.4% and is now trading at $55.22.
View the best growth stocks for 2024 here
.

Are investors shorting Novozymes A/S?

Novozymes A/S saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 506,800 shares, a drop of 38.8% from the March 31st total of 828,400 shares. Based on an average daily trading volume, of 600 shares, the days-to-cover ratio is presently 844.7 days.
View Novozymes A/S's Short Interest
.

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMF) released its quarterly earnings data on Wednesday, April, 20th. The biotechnology company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $2.43 by $2.06.

Is Novozymes A/S a good dividend stock?

Novozymes A/S (OTCMKTS:NVZMF) pays an annual dividend of $1.80 per share and currently has a dividend yield of 0.72%. The dividend payout ratio is 22.44%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Novozymes A/S?

Shares of NVZMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NVZMF) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners